论文信息 - 208TiP SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician’s choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+) / PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial - 字舞流文

208TiP SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician’s choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+) / PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial

B. Cantos | N. Martínez | E. Ciruelos | E. Martínez de Dueñas | B. Bermejo de las Heras | X. Gonzàlez | A. Prat | C. Arqueros Núñez | M. Melé Olivé | I. Fernández | A. Perello Martorell | S. Pernas Simon | M. Oliveira | J. de la Haba Rodríguez | E. Garate | J. Cortes | J. Ponce | E. Vega Alonso | A. Montaño Perianez | P. Villagrasa Gonzalez